Expanding the Clinical Spectrum of DRP2-Associated Charcot-Marie-Tooth Disease.
Neurology
journal-article
Epidemiology of ataxia and hereditary spastic paraplegia in Spain: A cross-sectional study.
Neurologia
journal-article
Efficacy and Safety of Leriglitazone in Patients With Friedreich Ataxia: A Phase 2 Double-Blind, Randomized Controlled Trial (FRAMES).
Neurology. Genetics
journal-article
Therapeutic plasma exchange for myasthenia gravis, Guillain-Barre syndrome, and other immune-mediated neurological diseases, over a 40-year experience
Expert Review of Neurotherapeutics
journal-article
Therapeutic plasma exchange for myasthenia gravis, Guillain-Barre syndrome, and other immune-mediated neurological diseases, over a 40-year experience.
Expert review of neurotherapeutics
journal-article
Epidemiology of ataxia and hereditary spastic paraplegia in Spain: a cross-sectional study.
Neurologia
journal-article
Serum glutamate decarboxylase antibodies and neurological disorders: when to suspect their association?
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
journal-article
'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab.
Journal of neurology
journal-article
Eculizumab improves fatigue in refractory generalized myasthenia gravis.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
journal-article
Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA).
Neurological research and practice
journal-article
Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
journal-article
Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study.
Journal of the neurological sciences
journal-article
Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis.
Neurology
journal-article
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.
Muscle & nerve
journal-article
Nonataxia symptoms in Friedreich Ataxia: Report from the Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS).
Neurology
journal-article
IGF-1 in autosomal dominant cerebellar ataxia - open-label trial.
Cerebellum & ataxias
journal-article
Triple therapy with darbepoetin alfa, idebenone, and riboflavin in Friedreich's ataxia: an open-label trial.
Cerebellum (London, England)
journal-article
Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia.
Human molecular genetics
journal-article
Guillain-Barré syndrome: natural history and prognostic factors: a retrospective review of 106 cases.
BMC neurology
journal-article
Triple therapy with deferiprone, idebenone and riboflavin in Friedreich's ataxia - open-label trial.
Acta neurologica Scandinavica
journal-article
Assessment of cognitive impairment in amyotrophic lateral sclerosis.
Journal of the neurological sciences
journal-article
Analysis of the C9orf72 gene in patients with amyotrophic lateral sclerosis in Spain and different populations worldwide.
Outcome of patients with amyotrophic lateral sclerosis attending in a multidisciplinary care unit.
Neurologia (Barcelona, Spain)
journal-article
[Development of a clinical pathway for the attention of patients with amyotrophic lateral sclerosis in a regional network. ALS Assistance Network-Comunidad de Madrid].
Neurologia (Barcelona, Spain)
journal-article
[Benign intracranial hypertension. History, clinical features and treatment in a series of 41 patients].